Nuclera closes $75 million USD financing
October 16, 2024
Series C round led by Elevage Medical Technologies Funding will accelerate the commercialization of Nuclera’s eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally Cambridge, UK, and Boston MA, USA: Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a [...]
Bio X Cell Announces Board of Director Appointments
October 16, 2024
A Leading Producer of Monoclonal Antibodies LEBANON, N.H. -- Bio X Cell, LLC ("BXC" or the "Company"), the world's leading producer of monoclonal antibodies for pre-clinical in vivo research applications, is pleased to announce the appointments of Alan Hirzel and Kevin Ballinger to its Board of Directors. "We are thrilled to welcome Alan Hirzel to the board alongside Kevin Ballinger, who joined earlier this [...]
Pillar Biosciences Announces Expansion of NGS Commercial Partnership with Illumina
October 16, 2024
Enables content for newly launched Illumina MiSeq™ i100 and expands Illumina oncology panel portfolio to include targeted liquid biopsy panels NATICK, Mass. -- Pillar Biosciences, Inc., the leader in Decision Medicine™, has today announced an expansion of their existing partnership with Illumina, through which a broader portfolio of Pillar's oncoReveal™ NGS panels will now be offered directly by Illumina. [...]
October 16, 2024
Univercells Technologies by Donaldson introduces the scale-X nexo bioreactor - offering a 0.5 m² growth surface, designed for efficient cell culture process development across multiple modalities. Nivelles, Belgium – Univercells Technologies by Donaldson, a global leader in bioprocessing technologies, proudly announces the launch of its latest innovation, the scale-X™ nexo bioreactor. This cutting-edge addition to the [...]
October 16, 2024
Element Biosciences has partnered with Integrated DNA Technologies (IDT) and Twist Bioscience to provide the necessary exome-targeting tools for the Trinity workflow SAN DIEGO, CA – Element Biosciences, Inc., a developer of pioneering technologies to empower science, today introduced Trinity™ - an innovative solution that simplifies target capture sequencing by eliminating or moving traditionally time-consuming steps to the AVITI™ [...]
Innovative Lab Services LLC Acquires MLS Technologies, Inc.
October 16, 2024
Acquisition expands core capabilities and service into the Pacific Northwest Market COLUMBUS, Ohio -- Innovative Lab Services LLC ("ILS"), a premier provider of analytical instrumentation solutions is thrilled to announce its acquisition of MLS Technologies, Inc. ("MLS"), a leading analytical instrument services and support company. This strategic combination will significantly extend the core capabilities, technical [...]
October 15, 2024
San Diego, CA – Nucleus Biologics, a leading provider of cell culture and bioprocessing solutions for the cell and gene therapy (CGT) industry, has launched NB-KUL DF, a DMSO-free, chemically-defined cryomedia set to redefine cryopreservation standards. Designed for CGT manufacturers, NB-KUL DF matches DMSO-based media performance and outperforms other DMSO-free options in cell viability, recovery, [...]
Telescope Innovations Becomes Certified Systems Integrator of Universal Robots
October 15, 2024
Certification enables faster development and deployment of Telescope’s Self-Driving Labs Vancouver BC — Telescope Innovations Corp. (“Telescope Innovations” or the “Company”) (CSE: TELI) (OTCQB: TELIF), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, announces its achievement of Certified Systems Integrator (“CSI”) status for robotic instruments sold by Universal Robots (“UR”). [...]
bit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell Programming Technology
October 15, 2024
The European Patent Office (EPO) upholds bit.bio's patent for its dual genomic safe harbour technology, opti-ox™, securing the broadest possible claims for programming of pluripotent stem cells (PSCs) into any cell type. Much like how CRISPR transformed genome editing, opti-ox establishes a new paradigm for the safe, consistent, and scalable manufacture of iPSC-derived cells. The successful [...]
Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing
October 15, 2024
Collaboration to Enable Sequencing of Cells while Preserving Their Viability Zürich, Switzerland, and Vienna, Austria – Cytosurge AG, a leader in single-cell manipulation, and Lexogen, a pioneer in RNA sequencing solutions, have announced their partnership to advance live-cell sequencing (Live-seq). The collaboration integrates Cytosurge's FluidFM® OMNIUM platform with Lexogen's LUTHOR HD kit to offer a streamlined [...]

